Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.23
-0.08 (-1.27%)
At close: Oct 21, 2025, 4:00 PM EDT
6.24
+0.01 (0.16%)
After-hours: Oct 21, 2025, 7:07 PM EDT
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $45.62 million as of October 21, 2025. Its market cap has decreased by -21.59% in one year.
Market Cap
45.62M
Enterprise Value
-43.15M
1-Year Change
-21.59%
Ranking
Category
Stock Price
$6.23
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $45.62M, a decrease of -85.97%. That is a compound annual growth rate of -23.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 45.62M | -6.95% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | 241.52M | 214.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |